New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...

Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...

New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.

Experts discuss the underutilization of biomarker testing in metastatic lung cancer, emphasizing the need for improved ...

Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...

Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

BeiGene is back with a new partnership and oncology campaign to raise awareness about biomarker testing for patients with chronic lymphocytic leukemia (CLL), a blood cancer marked by the ...

Almost all of us have been touched by cancer at some point in our lives. If we haven’t had it, chances are we know a loved one or a friend who has. When someone dies from cancer, families go through ...

A new international study has demonstrated that Alzheimer's disease biomarkers can be accurately detected using simple finger ...

A simple blood test can tell doctors when it is safe to stop antibiotics in patients recovering from sepsis, a review led by ...